![]() |
Volumn 77, Issue 8, 2003, Pages 5037-5038
|
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
CD4 ANTIGEN;
EFAVIRENZ;
LAMIVUDINE;
LOPINAVIR PLUS RITONAVIR;
TENOFOVIR;
ANTIVIRAL ACTIVITY;
ARTICLE;
CELL DEATH;
CELL FUNCTION;
CELL KINETICS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
DRUG POTENCY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MATHEMATICAL MODEL;
MOLECULAR DYNAMICS;
NONHUMAN;
NONLINEAR REGRESSION ANALYSIS;
PRIORITY JOURNAL;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
VIRUS REPLICATION;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
CD4-POSITIVE T-LYMPHOCYTES;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
MODELS, BIOLOGICAL;
REVERSE TRANSCRIPTASE INHIBITORS;
RNA, VIRAL;
VIRUS REPLICATION;
|
EID: 0037385686
PISSN: 0022538X
EISSN: None
Source Type: Journal
DOI: 10.1128/JVI.77.8.5037-5038.2003 Document Type: Article |
Times cited : (330)
|
References (7)
|